Biotronik Launches Lumax 540 Series Cardiac Rhythm Management Devices in U.S.

 

May 26, 2009

Biotronik's Lumax 540 series implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillator (CRT-D) devices offer remote, wireless monitoring when combined with the BIOTRONIK Home Monitoring system.

The Lumax 540 series enables continuous automatic data transmission of clinically relevant events. The information is available to physicians online, allowing them to monitor their patients’ cardiac and device status without patients having to visit the medical office.

The Lumax 540 series offers a full suite of programming solutions for state-of-the-art tachycardia therapy management that allows the physician to optimize therapy based on patients’ dynamic needs.

The Lumax 540 series DFT Manager allows physicians to noninvasively manage high-DFT patients using programmable shock pathways, waveforms, and polarities. The company said these features are designed to ensure that life-saving shock therapy is delivered successfully. Additional advanced features, including RVsense Triggering and Negative AV Hysteresis, ensure effective resynchronization therapy for heart-failure patients.

Lumax 540 devices offer technology to help reduce the pain and anxiety resulting from unnecessary shocks.